Skip to Main Content

Paper Details

Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021.
Pediatrics
41
2007
CD4, HIV, HIV-, HIV-1, HIV-1 RNA, HIV-1-infected, HIV-infected, Pediatric AIDS, RNA copies, adolescents, children, didanosine, efavirenz, emtricitabine, glucose, low-glucose, patients, plasma, rashes
Author NameAffiliation
Ross E McKinneyDuke University Medical Center
  • 1 - 1

Datasets

Release 1.2